WIN-63291
WIN-63291 is a selective and orally active phosphodiesterase (PDE) III inhibitor. WIN-63291 can be used for the research of cardiovascular disease[1].
Product Specifications
CAS Number
[144967-96-4]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Smiles
CC(N1)=C(C=C(C#N)C1=O)C2=CC=C(N=CC=C3)C3=C2
Molecular Formula
C16H11N3O
Molecular Weight
261.28
References & Citations
[1]Pagani ED, et al. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582. J Cardiovasc Pharmacol. 1994 Sep;24 (3) :403-10.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1244251-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Stationary phase protein 4 (SPG4)
Ask
View Details 
MBS1244251-02 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Stationary phase protein 4 (SPG4)
Ask
View Details MBS1244251-03 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Stationary phase protein 4 (SPG4)
Ask
View Details MBS1244251-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Stationary phase protein 4 (SPG4)
Ask
View Details MBS1244251-05 0.02 mg (Baculovirus)
Recombinant Saccharomyces cerevisiae Stationary phase protein 4 (SPG4)
Ask
View Details MBS1244251-06 1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Stationary phase protein 4 (SPG4)
Ask
View Details